Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Tax Provisions: 2018-2024

Historic Tax Provisions for Silence Therapeutics (SLN) over the last 7 years, with Dec 2024 value amounting to $845,000.

  • Silence Therapeutics' Tax Provisions fell 97.96% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $21,000, marking a year-over-year decrease of 97.20%. This contributed to the annual value of $845,000 for FY2024, which is 11.61% down from last year.
  • Silence Therapeutics' Tax Provisions amounted to $845,000 in FY2024, which was down 11.61% from $956,000 recorded in FY2023.
  • Silence Therapeutics' Tax Provisions' 5-year high stood at $956,000 during FY2023, with a 5-year trough of -$8.9 million in FY2021.
  • Its 3-year average for Tax Provisions is $829,667, with a median of $845,000 in 2024.
  • In the last 5 years, Silence Therapeutics' Tax Provisions crashed by 97.67% in 2021 and then skyrocketed by 107.76% in 2022.
  • Silence Therapeutics' Tax Provisions (MRY) stood at -$4.5 million in 2020, then crashed by 97.67% to -$8.9 million in 2021, then surged by 107.76% to $688,000 in 2022, then skyrocketed by 38.95% to $956,000 in 2023, then fell by 11.61% to $845,000 in 2024.
  • Its Tax Provisions stands at $845,000 for FY2024, versus $956,000 for FY2023 and $688,000 for FY2022.